Brynovin Solution
Product Images NDC 24338-017

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Brynovin (NDC 24338-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

A line graph showing least squares mean change from baseline over 24 weeks for various treatments in a patient population. The x-axis represents time in weeks (0, 6, 12, 18, 24) and the y-axis shows the LS mean change from baseline, ranging from 0 to -2. Different treatment groups are indicated with symbols: placebo, sitagliptin 100 mg once daily, metformin 500 mg twice daily, metformin 1000 mg twice daily, sitagliptin 50 mg twice daily with metformin 500 mg twice daily, and sitagliptin 50 mg twice daily with metformin 1000 mg twice daily. The graph illustrates changes over time for each treatment group, with all least squares means adjusted for prior antihyperglycemic therapy and baseline value.*

FDA Label Image

Figure-2 (Figure 2)

A line graph comparing the least squares (LS) mean change from baseline over 52 weeks for Sitagliptin 100 mg and Glipizide treatments. The x-axis represents time in weeks, while the y-axis shows the LS mean change from baseline, demonstrating a decrease initially followed by a gradual increase towards baseline values.*

FDA Label Image

Sitagliptin Bottle Label (Sitagliptin Bottle Label)

BRYNOVIN (sitagliptin) Oral Solution 25 mg/mL label showing 120 mL bottle size, manufactured by Azurity Pharmaceuticals, Inc. Instructions include refrigeration storage at 2°C to 8°C, protection from light, and discard 90 days after opening. The label displays dosage information, NDC 24338-017-01, and is marked Rx Only.*

FDA Label Image

Sitagliptin Carton Label (Sitagliptin Carton Label)

BRYNOVIN (sitagliptin) Oral Solution 25 mg/mL carton label for a 120 mL bottle. The label indicates the product is for oral administration only and is ready to use. It is manufactured by Azurity Pharmaceuticals, Inc. and Delpharm Montreal, Inc. Storage instructions include refrigeration at 2°C - 8°C and protection from light. The label includes warnings to keep out of reach of children and discard unused portion 90 days after opening.*

FDA Label Image

Structure (Structure)

Chemical structure of Sitagliptin Hydrochloride, shown with three fluorine atoms on the aromatic ring, an amine group, and a trifluoromethyl group attached to a triazolopiperazine ring. The structure also indicates the presence of hydrochloride hydrate (HCl.H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.